mrd in pediatric all: clinical evidence, treatment decisions & outcomes
Published 5 years ago • 468 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:05
the importance of using mrd to guide treatment decisions in all
-
5:17
approaches to and the use of mrd in all
-
2:16
mrd: making clinical decisions in all
-
0:46
the importance of mrd assessment in all phases of all treatment
-
2:37
evidence supporting mrd-guided treatment breaks in mm
-
2:07
using mrd to improve patient outcomes
-
1:39
how can mrd guide treatment of aml?
-
3:35
the role of mrd in all: what defines a complete response?
-
2:35
an update on mrd assessment and novel techniques used in the treatment of hematological malignancies
-
1:52
improving the use of mrd for the prognosis and treatment of all
-
2:51
mrd testing in acute leukemias
-
3:01
minimal residual disease: a key determinant of all treatment response
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
3:35
minimal residual disease (mrd) as a prognostic factor for acute myeloid leukemia (aml)
-
1:33
the difficulties of mrd detection in dlbcl
-
1:32
methods to evaluate mrd in aml
-
5:19
circulating micrornas as mrd biomarkers in pediatric all
-
0:36
mrd studies in all and aml
-
15:02
the evolving landscape of all therapy and the impact of mrd